As of now, Switzerland reports a research & development by business enterprise, pharmaceutical industry in current ppp $ of 5,969.31 million, signifying an increase of 902.62 million (17.8%) from 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Switzerland
No matching regions
Similar regions to Switzerland
Business R&D pharmaceutical in current PPP $
More indicators for Switzerland
Government R&D in security as % of government support
0.57%
+0.16%
(2021)
Higher-education-finacing R&D financed by general university in local currency
45,166.20M
+1,982.46M
(2021)
R&D financed by rest of the world in local currency
13,491.13M
-451.15M
(2021)
Government R&D financed by rest of the world in local currency
37.06M
+1.86M
(2022)
Business R&D financed by rest of the world in local currency
10,446.47M
-500.14M
(2021)
Non-profit R&D growth rate
1.79%
-4.45%
(2021)
Switzerland Business R&D pharmaceutical in current PPP $ between 1996 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 5,969.31M | +902.62M |
| 2020 | 5,066.69M | +512.32M |
| 2019 | 4,554.37M | +265.21M |
| 2018 | 4,289.16M | +108.78M |
| 2017 | 4,180.38M | +356.97M |
| 2016 | 3,823.41M | +477.38M |
| 2015 | 3,346.03M | +353.26M |
| 2014 | 2,992.77M | +149.72M |
| 2013 | 2,843.05M | +37.47M |
| 2012 | 2,805.58M | -60.33M |
| 2011 | 2,865.91M | -47.26M |
| 2010 | 2,913.17M | -154.01M |
| 2009 | 3,067.18M | -32.51M |
| 2008 | 3,099.70M | +121.88M |
| 2007 | 2,977.82M | +268.40M |
| 2006 | 2,709.42M | +346.61M |
| 2005 | 2,362.81M | +255.17M |
| 2004 | 2,107.64M | +291.25M |
| 2003 | 1,816.39M | +259.90M |
| 2002 | 1,556.49M | +297.68M |
| 2001 | 1,258.81M | +233.44M |
| 2000 | 1,025.36M | +192.86M |
| 1999 | 832.51M | +166.57M |
| 1998 | 665.93M | +142.00M |
| 1997 | 523.93M | +136.23M |
| 1996 | 387.70M |